Urinary Tract Infections Caused by Uropathogenic Escherichia coli: Mechanisms of Infection and Treatment Options

被引:93
作者
Zhou, Yang [1 ,2 ]
Zhou, Zuying [1 ,2 ]
Zheng, Lin [1 ,2 ]
Gong, Zipeng [1 ]
Li, Yueting [1 ]
Jin, Yang [1 ]
Huang, Yong [1 ,2 ]
Chi, Mingyan [1 ,2 ]
机构
[1] Guizhou Med Univ, State Key Lab Funct & Applicat Med Plants, Guizhou Prov Key Lab Pharmaceut, 4 Beijing Rd, Guiyang 550004, Peoples R China
[2] Guizhou Med Univ, Sch Pharmaceut Sci, 4 Beijing Rd, Guiyang 550004, Peoples R China
基金
中国国家自然科学基金;
关键词
urinary tract infections; uropathogenic Escherichia coli; alternative treatment options; INTRACELLULAR BACTERIAL COMMUNITIES; SPECTRUM BETA-LACTAMASES; SECRETED AUTOTRANSPORTER TOXIN; ENTERICA SEROTYPE TYPHIMURIUM; VITRO ANTIBACTERIAL ACTIVITY; SIDEROPHORE RECEPTOR IRON; CITRUS-RETICULATA BLANCO; VAGINAL MUCOSAL VACCINE; TROPAEOLI-MAJORIS HERBA; INNATE IMMUNE-RESPONSE;
D O I
10.3390/ijms241310537
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Urinary tract infections (UTIs) are common bacterial infections that represent a severe public health problem. They are often caused by Escherichia coli (E. coli), Klebsiella pneumoniae (K. pneumonia), Proteus mirabilis (P. mirabilis), Enterococcus faecalis (E. faecalis), and Staphylococcus saprophyticus (S. saprophyticus). Among these, uropathogenic E. coli (UPEC) are the most common causative agent in both uncomplicated and complicated UTIs. The adaptive evolution of UPEC has been observed in several ways, including changes in colonization, attachment, invasion, and intracellular replication to invade the urothelium and survive intracellularly. While antibiotic therapy has historically been very successful in controlling UTIs, high recurrence rates and increasing antimicrobial resistance among uropathogens threaten to greatly reduce the efficacy of these treatments. Furthermore, the gradual global emergence of multidrug-resistant UPEC has highlighted the need to further explore its pathogenesis and seek alternative therapeutic and preventative strategies. Therefore, a thorough understanding of the clinical status and pathogenesis of UTIs and the advantages and disadvantages of antibiotics as a conventional treatment option could spark a surge in the search for alternative treatment options, especially vaccines and medicinal plants. Such options targeting multiple pathogenic mechanisms of UPEC are expected to be a focus of UTI management in the future to help combat antibiotic resistance.
引用
收藏
页数:33
相关论文
共 283 条
[1]   Ethnopharmacological survey and in vitro evaluation of wound-healing plants used in South-western Nigeria [J].
Adetutu, Adewale ;
Morgan, Winston A. ;
Corcoran, Olivia .
JOURNAL OF ETHNOPHARMACOLOGY, 2011, 137 (01) :50-56
[2]   Pathogenomics of uropathogenic Escherichia coli [J].
Agarwal, J. ;
Srivastava, S. ;
Singh, M. .
INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2012, 30 (02) :141-149
[3]   A randomised, double-blind, placebo-control led trial of a herbal medicinal product containing Tropaeoli majoris herba (Nasturtium) and Armoraciae rusticanae radix (Horseradish) for the prophylactic treatment of patients with chronically recurrent lower urinary tract infections [J].
Albrecht, Uwe ;
Goos, Karl-Heinz ;
Schneider, Berthold .
CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (10) :2415-2422
[4]   Mucosal Immunization with Iron Receptor Antigens Protects against Urinary Tract Infection [J].
Alteri, Christopher J. ;
Hagan, Erin C. ;
Sivick, Kelsey E. ;
Smith, Sara N. ;
Mobley, Harry L. T. .
PLOS PATHOGENS, 2009, 5 (09)
[5]   Host subversion by formation of intracellular bacterial communities in the urinary tract [J].
Anderson, GG ;
Martin, SM ;
Hultgren, SJ .
MICROBES AND INFECTION, 2004, 6 (12) :1094-1101
[6]  
Anger J, 2019, J UROLOGY, V202, P282, DOI [10.1097/JU.0000000000000296, 10.1097/JU.0000000000000503]
[7]  
Ashraf K, 2018, J PHARM BIOALLIED SC, V10, P109, DOI [10.4103/jpbs.JPBS_253_17, 10.4103/JPBS.JPBS_253_17]
[8]   Identification of target tissue glycosphingolipid receptors for uropathogenic, F1C-fimbriated Escherichia coli and its role in mucosal inflammation [J].
Bäckhed, F ;
Alsén, B ;
Roche, N ;
Ångström, J ;
von Euler, A ;
Breimer, ME ;
Westerlund-Wikström, B ;
Teneberg, S ;
Richter-Dahlfors, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (20) :18198-18205
[9]   Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents [J].
Bader, Mazen S. ;
Loeb, Mark ;
Leto, Daniela ;
Brooks, Annie A. .
POSTGRADUATE MEDICINE, 2020, 132 (03) :234-250
[10]   An update on the management of urinary tract infections in the era of antimicrobial resistance [J].
Bader, Mazen S. ;
Loeb, Mark ;
Brooks, Annie A. .
POSTGRADUATE MEDICINE, 2017, 129 (02) :242-258